Patent 7312079 was granted and assigned to Lexicon Pharmaceuticals, Inc. on December, 2007 by the United States Patent and Trademark Office.
Polynucleotide and polypeptide sequences that encode novel variant FAM3C proteins are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.